Acute tryptophan depletion reduces kynurenine levels: implications for treatment of impaired visuospatial memory performance in irritable bowel syndrome

详细信息    查看全文

• 作者：Paul J. Kennedy ; Andrew P. Allen ; Ann O’Neill ; Eamonn M. M. Quigley…
• 关键词：CANTAB? ; Cognition ; Cognitive impairment ; Visuospatial memory ; Paired Associates Learning ; Irritable bowel syndrome (IBS) ; Brain ; gut axis ; Acute tryptophan depletion ; Kynurenine
• 刊名：Psychopharmacology
• 出版年：2015
• 出版时间：April 2015
• 年：2015
• 卷：232
• 期：8
• 页码：1357-1371
• 全文大小：487 KB
• 参考文献：1. Aizawa, E, Sato, Y, Kochiyama, T, Saito, N, Izumiyama, M, Morishita, J, Kanazawa, M, Shima, K, Mushiake, H, Hongo, M, Fukudo, S (2012) Altered cognitive function of prefrontal cortex during error feedback in patients with irritable bowel syndrome, based on FMRI and dynamic causal modeling. Gastroenterology 143: pp. 1188-1198 CrossRef
  2. Alexander, KS, Wu, H-Q, Schwarcz, R, Bruno, JP (2012) Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine. Psychopharmacology 220: pp. 627-637 CrossRef
  3. Aron, AR, Fletcher, PC, Bullmore, T, Sahakian, BJ, Robbins, TW (2003) Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat Neurosci 6: pp. 115-116 CrossRef
  4. Badawy, A (2013) Novel nutritional treatment for manic and psychotic disorders: a review of tryptophan and tyrosine depletion studies and the potential of protein-based formulations using glycomacropeptide. Psychopharmacology 228: pp. 347-358 CrossRef
  5. Beck, AT, Steer, RA, Brown, GK (1996) Manual for the Beck Depression Inventory-II. Psychological Corporation, San Antonio
  6. Berman, S, Suyenobu, B, Naliboff, BD, Bueller, J, Stains, J, Wong, H, Mandelkern, M, Fitzgerald, L, Ohning, G, Gupta, A (2012) Evidence for alterations in central noradrenergic signaling in irritable bowel syndrome. NeuroImage 63: pp. 1854-1863 CrossRef
  7. Blackwell, AD, Sahakian, BJ, Vesey, R, Semple, JM, Robbins, TW, Hodges, JR (2004) Detecting dementia: novel neuropsychological markers of preclinical Alzheimer’s disease. Dement Feriatric Cogn 17: pp. 42-48 CrossRef
  8. Blankstein, U, Chen, J, Diamant, NE, Davis, KD (2010) Altered brain structure in irritable bowel syndrome: potential contributions of pre-existing and disease-driven factors. Gastroenterology 138: pp. 1783-1789 CrossRef
  9. Bond, A, Lader, M (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47: pp. 211-218 CrossRef
  10. Buysse, DJ, Reynolds, CF, Monk, TH, Berman, SR, Kupfer, DJ (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28: pp. 193-213 CrossRef
  11. Capuron, L, Miller, AH (2011) Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther 130: pp. 226-238 CrossRef
  12. Capuron, L, Neurauter, G, Musselman, DL, Lawson, DH, Nemeroff, CB, Fuchs, D, Miller, AH (2003) Interferon-alpha-induced changes in tryptophan metabolism. Relationship to depression and paroxetine treatment. Biol Psychiatry 54: pp. 906-914 CrossRef
  13. Chase, HW, Crockett, MJ, Msetfi, RM, Murphy, RA, Clark, L, Sahakian, BJ, Robbins, TW (2011) 5-HT modulation by acute tryptophan depletion of human instrumental contingency judgements. Psychopharmacology 213: pp. 615-623 CrossRef
  14. Chess, AC, Simoni, MK, Alling, TE, Bucci, DJ (2007) Elevations of endogenous kynurenic acid produce spatial working memory deficits. Schizophr Bull 33: pp. 797-804 CrossRef
  15. Chess, AC, Landers, AM, Bucci, DJ (2009) L-kynurenine treatment alters contextual fear conditioning and context discrimination but not cue-specific fear conditioning. Behav Brain Res 201: pp. 325-331 CrossRef
  16
• 刊物类别：Biomedical and Life Sciences
• 刊物主题：Biomedicine
  Pharmacology and Toxicology
  Psychiatry
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1432-2072

文摘

Rationale A visuospatial episodic memory impairment has recently been identified in irritable bowel syndrome. Increased tryptophan metabolism along the kynurenine pathway has also been reported in irritable bowel syndrome, which may play a role in altered cognitive performance as peripheral kynurenine can cross the blood brain barrier and lead to the production of neuroactive metabolites, which modulate glutamatergic and cholinergic signalling, key neurotransmitter systems involved in cognitive function. Objectives Utilising the acute tryptophan depletion (ATD) protocol, the aim of this study was to examine if manipulating peripheral levels of tryptophan regulates cognitive performance in irritable bowel syndrome and also to determine for the first time if the ATD protocol alters kynurenine supply to the central nervous system. Methods In this double-blind, placebo-controlled, crossover design study, nine female patients with irritable bowel syndrome and 14 matched female healthy controls participant completed a range of tests from the CANTAB? following ATD and placebo. Plasma tryptophan and kynurenine, self-report measures of gastrointestinal symptoms, mood and arousal were determined pre- and post-treatment on each study day. Results Following placebo (p--.016) but not ATD (p--.05), patients with irritable bowel syndrome exhibited impaired visuospatial memory performance (Paired Associates Learning (PAL) test). In addition, ATD significantly decreased (p--.001) and placebo significantly increased (p--.001) plasma kynurenine levels in both groups. Conclusions Manipulating peripheral tryptophan and kynurenine levels using ATD modulates hippocampal-mediated cognitive performance in irritable bowel syndrome but not healthy controls. These data may have important implications for reducing cognitive impairment in irritable bowel syndrome.